In multiple papers, it has been suggested that exposure to IL-21 alone causes lymphocytes to remain in or differentiate into a minimally differentiated phenotype (CD62L+CD44−), and that these lymphocytes have greater anti-tumor capacity relative to cells expanded in other gamma chain cytokines [25,34,36]. This evidence concerns the gene CD44 and neoplasm.